Preprint Sex differences in symptomatology and immune profiles of Long COVID, 2024, Silva, Putrino, Iwasaki et al.

Discussion in 'Long Covid research' started by SNT Gatchaman, Mar 3, 2024.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,485
    Location:
    Aotearoa New Zealand
    Sex differences in symptomatology and immune profiles of Long COVID
    Julio Silva; Takehiro Takahashi; Jamie Wood; Peiwen Lu; Sasha Tabachnikova; Jeffrey Gehlhausen; Kerrie Greene; Bornali Bhattacharjee; Valter Silva Monteiro; Carolina Lucas; Rahul Dhodapkar; Laura Tabacof; Mario Pena-Hernandez; Kathy Kamath; Tianyang Mao; Dayna Mccarthy; Ruslan Medzhitov; David van Dijk; Harlan Krumholz; Leying Guan; David Putrino; Akiko Iwasaki

    Strong sex differences in the frequencies and manifestations of Long COVID (LC) have been reported with females significantly more likely than males to present with LC after acute SARS-CoV-2 infection1-7. However, whether immunological traits underlying LC differ between sexes, and whether such differences explain the differential manifestations of LC symptomology is currently unknown.

    Here, we performed sex-based multi-dimensional immune-endocrine profiling of 165 individuals8 with and without LC in an exploratory, cross-sectional study to identify key immunological traits underlying biological sex differences in LC.

    We found that female and male participants with LC experienced different sets of symptoms, and distinct patterns of organ system involvement, with female participants suffering from a higher symptom burden. Machine learning approaches identified differential sets of immune features that characterized LC in females and males.

    Males with LC had decreased frequencies of monocyte and DC populations, elevated NK cells, and plasma cytokines including IL-8 and TGF-β-family members. Females with LC had increased frequencies of exhausted T cells, cytokine-secreting T cells, higher antibody reactivity to latent herpes viruses including EBV, HSV-2, and CMV, and lower testosterone levels than their control female counterparts. Testosterone levels were significantly associated with lower symptom burden in LC participants over sex designation.

    These findings suggest distinct immunological processes of LC in females and males and illuminate the crucial role of immune-endocrine dysregulation in sex-specific pathology.


    Link | PDF (Preprint: MedRxiv) [Open Access]
     
    ahimsa, Ash, Jacob Richter and 10 others like this.
  2. Andy

    Andy Committee Member

    Messages:
    21,995
    Location:
    Hampshire, UK
    EndME, ahimsa, Ash and 9 others like this.
  3. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,485
    Location:
    Aotearoa New Zealand
    Akiko Iwasaki's Twitter thread on the paper: via ThreadReader. Note the last comment —

     
    Sean and Lindberg like this.

Share This Page